The Ibogaine Story — Chapter 6: Bob Sisko
Outcomes Qualitative high
AI-extracted · unverified · confirm at source
Sisko's 9 paraclinical treatments (1987-1991) — first new human ibogaine trials in 25 years. Ibogaine interrupts cigarettes and methadone. Multiple case studies with Bwiti phenomenology.
Dosing: Weight-adjusted oral ibogaine HCl (99.7% purity); booster doses administered 1.5hr post-initial if needed; rectal aqueous solution as emergency anti-emetic route (oral)
Sample size: 9
Contraindications: Enabling behaviour from untreated partner (methadone smuggling documented), Nausea/vomiting risk requiring anti-emetic protocol, Pre-existing cardiac conditions (Baumann fatality reference — weak heart)